WADA to Monitor Tour de France Drug Testing
The World Anti-Doping Agency and the International Cycling Union signed an agreement Tuesday allowing WADA to monitor drug testing at this year's Tour de France, the AP reports.
Under the agreement, representatives from WADA will be able to observe all of the UCI's anti-doping procedures and have access to all related documents. Following the Tour, which runs July 3-25, WADA will also write a report on the UCI's anti-doping activities.
The UCI requested observers last October in an attempt to add transparency to their anti-doping efforts.